Isavuconazole: a new extended spectrum triazole for invasive mold diseases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isavuconazole: a new extended spectrum triazole for invasive mold diseases
Authors
Keywords
-
Journal
Future Microbiology
Volume 10, Issue 5, Pages 693-708
Publisher
Future Medicine Ltd
Online
2015-05-22
DOI
10.2217/fmb.15.34
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In VitroCombination of Isavuconazole with Micafungin or Amphotericin B Deoxycholate against Medically Important Molds
- (2014) Aspasia Katragkou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Therapy Protects Immunosuppressed Mice from Mucormycosis
- (2014) Guanpingsheng Luo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases
- (2014) Seyedmojtaba Seyedmousavi et al. Expert Review of Anti-Infective Therapy
- Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery
- (2014) B. M. Knoll JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey
- (2014) L. Pagano et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries
- (2014) P.E. Verweij et al. JOURNAL OF CHEMOTHERAPY
- Isavuconazole Treatment of a Patient with Disseminated Mucormycosis
- (2014) D. Peixoto et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method
- (2013) Susan J. Howard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Pharmacodynamic Target Determination for Candida Species in anIn VivoMurine Disseminated Candidiasis Model
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole (BAL4815) Pharmacodynamic Target Determination in anIn VivoMurine Model of Invasive Pulmonary Aspergillosis against Wild-Type andcyp51Mutant Isolates of Aspergillus fumigatus
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole
- (2013) Lea Gregson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on Voriconazole and Aspergillus spp.
- (2013) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Successful isavuconazole salvage therapy in a patient with invasive mucormycosis
- (2013) J. Ervens et al. INFECTION
- In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species
- (2012) Michaela Lackner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Pharmacodynamic Target Determination against Wild-Type andCyp51Mutant Isolates of Aspergillus fumigatus in anIn VivoModel of Invasive Pulmonary Aspergillosis
- (2012) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Clinical Manifestations of Mucormycosis
- (2012) George Petrikkos et al. CLINICAL INFECTIOUS DISEASES
- EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
- (2012) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections
- (2012) Joanne Livermore et al. Expert Opinion on Drug Metabolism & Toxicology
- Incidence and outcomes of invasive fungal disease in adult patients with acute lymphoblastic leukemia treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone: implications for prophylaxis
- (2012) Andrea Henden et al. LEUKEMIA & LYMPHOMA
- How I treat mucormycosis
- (2011) D. P. Kontoyiannis et al. BLOOD
- Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
- (2011) O. Lortholary et al. CLINICAL MICROBIOLOGY AND INFECTION
- Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
- (2011) A. Skiada et al. CLINICAL MICROBIOLOGY AND INFECTION
- The case for antifungal stewardship
- (2011) Michelle R. Ananda-Rajah et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Quantitation of Azoles and Echinocandins in Compartments of Peripheral Blood by Liquid Chromatography-Tandem Mass Spectrometry
- (2010) F. Farowski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
- (2010) Dimitrios P. Kontoyiannis et al. CLINICAL INFECTIOUS DISEASES
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
- (2010) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan
- (2010) Toshikazu Yamazaki et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection
- (2010) Susan Julie Howard et al. MEDICAL MYCOLOGY
- Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole
- (2010) George R. Thompson et al. MYCOPATHOLOGIA
- Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence
- (2010) Maiken Cavling Arendrup et al. PLoS One
- Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
- (2009) A. Schmitt-Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to the Methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2009) S. Perkhofer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of a Novel Triazole, Isavuconazole: Mathematical Modeling, Importance of Tissue Concentrations, and Impact of Immune Status on Antifungal Effect
- (2009) P. A. Warn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
- (2009) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
- (2009) Paul E Verweij et al. LANCET INFECTIOUS DISEASES
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species
- (2008) J. Guinea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections
- (2008) Jesús Guinea et al. Future Microbiology
- Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei
- (2008) J. Majithiya et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitroactivities of isavuconazole against opportunistic filamentous and dimorphic fungi
- (2008) Gloria M. González MEDICAL MYCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More